Hemalkumar Mehta, PhD

  • 241 Citations
  • 9 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Hemalkumar Mehta is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles
Urinary Bladder Neoplasms Medicine & Life Sciences
Cystectomy Medicine & Life Sciences
Comorbidity Medicine & Life Sciences
Mortality Medicine & Life Sciences
Dementia Medicine & Life Sciences
Medicare Medicine & Life Sciences
Costs and Cost Analysis Medicine & Life Sciences
Diagnosis-Related Groups Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2021

Research Output 2012 2019

  • 241 Citations
  • 9 h-Index
  • 41 Article
  • 1 Comment/debate
  • 1 Editorial
  • 1 Letter
2 Citations (Scopus)

Comparison of Costs of Radical Cystectomy vs Trimodal Therapy for Patients with Localized Muscle-Invasive Bladder Cancer

Williams, S., Shan, Y., Ray-Zack, M., Hudgins, H. K., Jazzar, U., Tyler, D., Freedland, S. J., Swanson, T., Baillargeon, J., Hu, J. C., Kaul, S., Kamat, A. M., Gore, J. L. & Mehta, H., Jan 1 2019, In : JAMA Surgery.

Research output: Contribution to journalArticle

Urinary Bladder Neoplasms
Costs and Cost Analysis

Cost of benign versus oncologic colon resection among fee-for-service Medicare enrollees

Hughes, B. D., Hancock, K. J., Shan, Y., Thakker, R. A., Maharsi, S., Tyler, D., Mehta, H. & Senagore, A. J., Aug 1 2019, In : Journal of Surgical Oncology. 120, 2, p. 280-286 7 p.

Research output: Contribution to journalArticle

Fee-for-Service Plans
Diagnosis-Related Groups

Diagnosis-Related Group in Colon Surgery: Identifying Areas of Improvement to Drive High-Value Care

Hughes, B. D., Moore, S. A., Mehta, H., Shan, Y. & Senagore, A. J., Mar 1 2019, In : The American surgeon. 85, 3, p. 256-260 5 p.

Research output: Contribution to journalArticle

Diagnosis-Related Groups
Length of Stay
State Hospitals
Hospital Economics

The concomitant use of tyrosine kinase inhibitors and proton pump inhibitors: Prevalence, predictors, and impact on survival and discontinuation of therapy in older adults with cancer

Sharma, M., Holmes, H. M., Mehta, H., Chen, H., Aparasu, R. R., Shih, Y. C. T., Giordano, S. H. & Johnson, M. L., Jan 1 2019, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Proton Pump Inhibitors
Protein-Tyrosine Kinases